Is Moderna Stock A Buy As It Faces Off With Pfizer, GSK In The Massive RSV Market?Investors Business Daily • 02/15/23
Here are five companies to pick if Goldman Sachs is right about the stock market being flat in 2023Market Watch • 02/13/23
Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical TrialsBusiness Wire • 02/03/23
Moderna to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 23, 2023Accesswire • 02/02/23
This Discount Growth Stock Is a Once-in-a-Decade Buying Opportunity Right NowThe Motley Fool • 01/31/23
Moderna's stock is down as Pfizer lowers revenue estimates for its COVID vaccine for 2023Market Watch • 01/31/23
Moderna (MRNA) RSV Jab For Older Adults Gets FDA Breakthrough TagZacks Investment Research • 01/31/23
The RSV Vaccine Battle Wages On With Moderna Scoring A Win Vs. Pfizer, GSKInvestors Business Daily • 01/30/23
Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine CandidateAccesswire • 01/30/23
2 Struggling Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the PlagueThe Motley Fool • 01/29/23
Pharmaceutical Stocks Pfizer, GSK, Moderna Come Close To Cracking A Multibillion-Dollar RSV Vaccine MarketInvestors Business Daily • 01/19/23